Our top 10 ALS news stories of 2025 feature actor Eric Dane’s advocacy and major research milestones in the field.

Actor Eric Dane, who lives with ALS, has joined the board of directors of the U.S. nonprofit Target ALS, with an aim of ...

MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...

The close of the brief wreath-making season reminds columnist Kristin Neva how much different it is than being a long-term ...

NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...

Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...

Neurosense Therapeutics said it will seek conditional approval of PrimeC as an ALS treatment in Canada in mid-2006.

ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

Columnist Juliet Taylor and her late husband, Jeff, fought hard for precious holiday moments after he was diagnosed with ALS.

Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.

While briefly changing roles with her husband, columnist Kristin Neva got a glimpse of how frustrating it is to have difficulty speaking.